© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 12, 1002-1003,
June 16, 1999
© 1999 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The American Society of Clinical Oncology gave John R. Durant, M.D., its Special Recognition Award in honor of his "noteworthy" 4-year tenure as ASCO's first executive vice president. Durant, who has led the organization since 1995, announced last year that he would retire as soon as a replacement could be found.
|
Durant is credited with transforming ASCO into a self-managed society. For 31 years, it had been managed by an outside company and until 1995 had only three employees. Now, ASCO's budget has doubled, it has 10 departments, 12,000 members, and a staff of 60.
Under Durant's guidance, the society became the major voice for clinical cancer physicians on health care policy issues. It produces 29 publications, including its flagship Journal of Clinical Oncology, and maintains a website, ASCO OnLine.
Durant was the founding director in the 1970's of the University of Alabama at Birmingham cancer center, became president of the Fox Chase Cancer Center, Philadelphia, returned to Birmingham as UAB's vice president for health affairs, then joined ASCO.
ASCI Award to Klausner
The American Society for Clinical Investigation, Chicago, recently presented its highest honor, the ASCI Award, to Richard D. Klausner, M.D., "for outstanding research accomplishments and mentoring."
|
Klausner is director of the National Cancer Institute and a past president of ASCI, an honor society for physician-scientists. The ASCI award is given to an active member of the society. Its members have won 15 Nobel prizes and 27 Lasker awards, and 122 members have been elected to the National Academy of Sciences.
Editorial Awards
The American Society for Blood and Marrow Transplantation, Arlington Heights, Ill., named two medical investigators as the first recipients of new editorial awards named in honor of bone marrow transplantation pioneers.
William R. Drobyski, M.D., of the Froedtert East Hospital, Milwaukee, Wis., won the George Santos Award for best clinical science paper, and Michael Jensen, M.D., of the Beckman Research Institute, City of Hope National Medical Center, Duarte, Calif., received the Ernest McCulloch & James Till Award for best basic science paper. The papers were published in ASBMT's journal.
Robb Named Chair
The University of Texas M. D. Anderson Cancer Center, Houston, said that Geoffrey L. Robb, M.D., has been appointed chairman of the Department of Plastic Surgery. He has been interim chair since 1997.
Robb, a professor, also serves as deputy head of the Division of Surgery, medical director of the Surgical Specialty Center, and associate medical director of the Skin Center at M. D. Anderson.
NCI Appointment
The National Cancer Institute announced that Suresh Mohla, Ph.D., is chief of the Tumor Biology Branch in its Division of Cancer Biology. The branch supports research on the molecular mechanisms of tumor progression and metastasis.
Mohla joined NCI in 1990 and has been a program director in basic cancer biology since 1992. He has been acting chief of the Tumor Biology Branch since last fall.
New ASCO President
The American Society of Clinical Oncology announced that Joseph S. Bailes, M.D., began his term as the society's president during the organization's recent annual meeting. It also announced that Lawrence H. Einhorn, M.D., was elected president for the term beginning next year, and that six individuals were elected as new board members.
|
Bailes is the national medical director of Physician Reliance Network, Inc., Dallas, an oncology physician practice management company. Einhorn is professor of medicine at Indiana University, Indianapolis. New board members are:
Arlene A. Forastiere, M.D., professor of oncology and otolaryngology at Johns Hopkins University School of Medicine, Baltimore; Sandra J. Horning, M.D., professor of medicine at Stanford University, Palo Alto, Calif.; Philip J. Stella, M.D., a medical oncologist in private practice in Ann Arbor, Mich.
Also, Michael P. Link, M.D., professor of pediatrics at Stanford; Janice P. Dutcher, M.D., associate director for clinical affairs at the cancer center of Our Lady of Lourdes Medical Center, New York; and Craig R. Nichols, M.D., professor of medicine at the Oregon Health Sciences University, Portland.
Circle of Life
The American Hospital Association, Chicago, is inaugurating the Circle of Life Award for innovation in end-of-life care. It will be given annually to up to three "exemplary programs" starting next year. Deadline for applying for the $25,000 award is Aug. 1.
The award is sponsored by AHA in conjunction with the American Medical Association, the American Association of Homes and Services for the Aging, and the National Hospice Organization. The award is funded by the Robert Wood Johnson Foundation, Princeton, N.J.
More information is available from AHA's Office of the Secretary at 312-422-2700, or a program can be nominated at the award web site (http://aha.org/circleoflife).
ONS Guidelines
The Oncology Nursing Press, Inc., Pittsburgh, just published the second edition of Cancer Chemotherapy Guidelines and Recommendations for Practice. The ONS-developed guidelines provide information on chemotherapy administration across all practice settings.
For information, call ONS customer service at 412-921-7373.
Prevention Fellowships
The National Cancer Institute's Cancer Prevention Fellowship Program is seeking applications for at least 3-year appointments that will begin July 1, 2000. Application deadline is Sept. 1.
The program provides a chance for physicians, other clinicians, and those with doctoral degrees to train in cancer prevention and control. It offers Master of Public Health training during the first year and independent research opportunities at NCI in later years.
Information is available from the program's director, Douglas L. Weed, M.D, Ph.D., or Barbara Redding. Phone is 301-496-8640, fax is 301-402-4863. Or e-mail Redding at br24v{at}nih.gov.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||